MAPT, microtubule associated protein tau, 4137

N. diseases: 469; N. variants: 292
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0234985
Disease: Mental deterioration
Mental deterioration
0.200 Biomarker phenotype BEFREE We have also developed a blood tau biomarker that correlates with a cognitive decline and also with neuroimaging determinations of brain atrophy. 31099321 2019
CUI: C0234985
Disease: Mental deterioration
Mental deterioration
0.200 Biomarker phenotype BEFREE Brain aging and Alzheimer's disease both demonstrate the accumulation of beta-amyloid protein containing "plaques" and tau protein containing "tangles" that contribute to accelerated memory loss and cognitive decline. 30728442 2019
CUI: C0234985
Disease: Mental deterioration
Mental deterioration
0.200 Biomarker phenotype BEFREE The incidence of Alzheimer's disease (AD), which is characterized by progressive cognitive decline that correlates with the spread of tau protein aggregation in the cortical mantle, is strongly age-related. 31249873 2019
CUI: C0234985
Disease: Mental deterioration
Mental deterioration
0.200 Biomarker phenotype BEFREE The aggregation of the tau protein into neurofibrillary tangles is believed to correlate with cognitive decline in several neurodegenerative disorders, including Alzheimer's disease. 31439664 2019
CUI: C0234985
Disease: Mental deterioration
Mental deterioration
0.200 Biomarker phenotype BEFREE The relationship between biomarkers of amyloid-beta aggregation (Aβ1-42) and/or neurodegeneration (Tau protein) in cerebrospinal fluid (CSF) and cognitive decline is still unclear. 31166546 2020